Table 1.
Conditions Associated with Liver Steatosis | Mechanism of Action | References |
---|---|---|
Alcohol (>20 g/day (women) or >30 g/day (men)) | Redox state shift: fatty acid oxidation inhibition, induction of lipogenesis Altered VLDL secretion in the liver |
[22] |
HCV | Altered VLDL secretion in the liver Insulin resistance Mitochondrial dysfunction and oxidative stress |
[23] |
Medications (e.g., methotrexate, corticosteroids, valproate) | Fatty acid oxidation inhibition, induction of lipogenesis Mitochondrial dysfunction Impaired hepatic lipid secretion Insulin resistance |
[24] |
Lipid metabolism disorders: a/hypo-betalipoproteinaemia, Wolman’s disease | Impaired hepatic lipid secretion Impaired hydrolysis of cholesteryl esters and triglycerides |
[25,26] |
Metal storage disorders: Wilson’s disease | Copper-induced mitochondrial dysfunction | [27] |
Autoimmune hepatitis | Drug-mediated effects | [28] |
Coeliac disease | Weight gain on gluten-free diet Impaired hepatic lipid mobilization Intestinal malabsorption |
[29] |
Endocrine disorders: hypothyroidism, hypopituitarism, polycystic ovary syndrome | Reduced hepatic lipid utilization Insulin resistance Impaired insulin secretion |
[30,31,32,33] |
Starvation, parenteral nutrition | Impaired hepatic lipid secretion Reduced mitochondrial beta-oxidation |
[34] |
Lipodystrophy | Insulin resistance and ectopic fat accumulation | [35] |